Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2021(PDF?174KB)

On May 12, 2021 Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) reported certain differences between its financial forecast on November 5, 2020, for the fiscal year ended March 31, 2021 (April 1, 2020, to March 31, 2021) and the actual results announced today (Press release, Sysmex, MAY 12, 2021, View Source [SID1234579879]). Furthermore, at a meeting of the Managing Board on May 12, 2021, Sysmex resolved to award dividends from surplus as described below, with a record date of March 31, 2021. We intend to propose this payment of dividends from surplus at the General Meeting of Shareholders scheduled for June 25, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

1. Change from Financial Forecasts
(1) Consolidated Financial Results for Fiscal Year from April 1, 2020, to March 31, 2021

(2) Reason
Consolidated net sales fell below our previous forecast mainly due the impact of the COVID-19 pandemic, which has been more prolonged than expected and led to lower-than-expected sales in the Americas and the Asia Pacific region. On the profit front, lower sales and a deteriorating cost of sales ratio caused gross profit to fall, but selling, general and administrative expenses declined because of restrictions on activities amid the COVID-19 pandemic. As a result, operating profit, profit before tax, and profit attributable to owners of the parent exceeded our previous forecast2.

Dividend from Surplus
(1) Dividend

(2) Reason
In terms of returns to shareholders, we intend to provide a stable dividend on a continuous basis and aim for a consolidated payout ratio of 30% under our basic policy of sharing the successes of our operations in line with business performance.

In accordance with this policy, we have set the ordinary year-end dividend for the fiscal year ended March 31, 2021, at ¥36 per share. Accordingly, annual total dividends will be ¥72 and the consolidated payout ratio will be 45.4%.